Zdrowie i gospodarka · 02/07/2026
Government Owned Invention Available for License: Chimeric VLP Vaccines To Prevent HTLV-1 Infection
The National Cancer Institute (NCI) is seeking collaborations with research partners and/or licensees to develop and commercialize Chimeric VLP Vaccines aimed at preventing HTLV-1 infection.